Podchaser Logo
Home
International Stem Cell Corporation

International Stem Cell Corporation

A Science and Medicine podcast
Good podcast? Give it some love!
International Stem Cell Corporation

International Stem Cell Corporation

Episodes
International Stem Cell Corporation

International Stem Cell Corporation

A Science and Medicine podcast
Good podcast? Give it some love!
Rate Podcast

Best Episodes of International Stem Cell Corporation

Mark All
Search Episodes...
TEMR: Welcome to The Ellis Martin Report.  I’m Bob Lange.  We’re talking with Kenneth Aldrich, Executive Chairman of International Stem Cell Corporation, trading on the OTC Market with the symbol ISCO.   International Stem Cell Corporation has
Ken Aldrich of International Stem Cell Corp (ISCO.OB) on the Present and Future of Stem Cell Research and ApplicationsThe Ellis Martin Report: International Stem Cell Corporation trades under the symbol ISCO.OB on the Over the Counter Bulle
This is Ken Aldrich.  I am Chairman of International Stem Cell Corporation and thought I’d talk for just a minute, or maybe a couple of minutes, about the different kinds of stem cells.  People are always asking, “What’s the difference between
Please take a moment to listen to International Stem Cell Corporation Chairman, Ken Aldrich, as he discusses the benefits of using human corneas developed in Petri dishes as an alternative to testing on the eyes of innocent rabbits.  This is
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human "parthenogenetic" stem cells from unfertilized eggs, has formed a partnership with
International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribu
OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred St
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here
Listen to an Interview of International Stem Cell Corporations CEO and Co Founder Kenneth Aldrich on Wallst.nethttp://www.wallst.net/audio/audio.asp?ticker=ISCO&id=4392
Welcome to this podcast. I am Ken Aldrich, Chairman and co-founder of International Stem Cell Corporation.International Stem Cell Corporation recently announced that our scientific team, led by our Chief Scientist, Dr. Elena Revazova, has cr
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features